Diethylstilbestrol and Conjunctival discoloration - from FDA reports
Conjunctival discoloration is reported only by a few people who take Diethylstilbestrol. We study 422 people who have side effects while taking Diethylstilbestrol from FDA. Among them, 1 have Conjunctival discoloration. Find out below who they are, when they have Conjunctival discoloration and more.
What to expect?
You are not alone!
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Nov, 24, 2017
422 people reported to have side effects when taking Diethylstilbestrol.
Among them, 1 person (0.24%) has Conjunctival discoloration
Number of reports submitted per year:
Gender of people who have Conjunctival discoloration when taking Diethylstilbestrol *:
- female: 0.0 %
- male: 100 %
Age of people who have Conjunctival discoloration when taking Diethylstilbestrol *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 100 %
- 50-59: 0.0 %
- 60+: 0.0 %
Top conditions involved for these people *:
- Type 2 Diabetes (1 person, 100.00%)
- Prostate Cancer (1 person, 100.00%)
- Pain (1 person, 100.00%)
- Metastases To Bone (1 person, 100.00%)
- Erection Problems (1 person, 100.00%)
Top co-used drugs for these people *:
- Zometa (1 person, 100.00%)
- Zofran (1 person, 100.00%)
- Viagra (1 person, 100.00%)
- Morphine (1 person, 100.00%)
- Ketoconazole (1 person, 100.00%)
Top other side effects for these people *:
- Purulent Discharge (1 person, 100.00%)
- Oropharyngeal Plaque (1 person, 100.00%)
- Indigestion (1 person, 100.00%)
- Appetite - Decreased (1 person, 100.00%)
- Abdominal Distension (1 person, 100.00%)
* Approximation only. Some reports may have incomplete information.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Subscribe to the study: get notified of updates to the study.
Do you have Conjunctival discoloration when taking Diethylstilbestrol?
- Check symptoms - is conjunctival discoloration caused by a drug or a condition?
- Get alerts to symptoms - forecast your symptoms and get alerts
- Join related support groups - you are not alone, join a support group on ehealth.me
- Report the side effect - help people in need and in real time
- Ask a question - ask a question related to the study
- write a review - share your experience related to the study
- More tools...
Expand the study to include all drugs with the same ingredientsConjunctival discoloration and drugs with ingredients of diethylstilbestrol.
Expand the study to include reports from both FDA and eHealthMeConjunctival discoloration and Diethylstilbestrol from FDA and eHealthMe reports
Diethylstilbestrol has active ingredients of diethylstilbestrol. (latest outcomes from Diethylstilbestrol 430 users)
Conjunctival discoloration has been reported by people with high blood pressure, depression, high blood cholesterol, hypothyroidism, hypertonic bladder (latest reports from 161 Conjunctival discoloration patients).
Browse all side effects of Diethylstilbestrola b c d e f g h i j k l m n o p q r s t u v w x y z
Drugs that are associated with Conjunctival discolorationConjunctival discoloration
Could your condition cause Conjunctival discolorationConjunctival discoloration
What would happen?
Questions to the study
Wondering if diethylstilbestrol causes adrenal problems? I am in preliminary testing due to poor health. SO rar, 24 hour urine test shows almost no cortisol, high blood sugar, insulin resistance, high testosterone, high DHEA, low SGBH, high estrogen... as you can hormonal imbalance. I have ...
User reviews to the study
My dad was diagnosed with PCa May2013. PSA 31, GS 4+5=9, T3N0M0, stage 3B He went thru RP, ADT every 3mos, 37 sessions of IGRT, bilateral orchietectomy, hyperbaric therapy and ZYTIGA but on aug 2016, he is now stage 4 with mets at bone, liver, nodes. He does not want chemo so we shifted to ...